Inhaled corticosteroids in COPD.

Inhaled corticosteroids in COPD.

Dettagli Bibliografici
Autori principali:	Brightling, C, Pavord, I
Natura:	Journal article
Lingua:	English
Pubblicazione:	1999

Documenti analoghi

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
di: Saha, S, et al.
Pubblicazione: (2006)

Inhaled corticosteroids in COPD (multiple letters) [1]
di: Hart, S, et al.
Pubblicazione: (1999)

Inhaled glucocorticoids and COPD exacerbations.
di: Brightling, C, et al.
Pubblicazione: (2015)

Minimising inhaled corticosteroids for COPD
di: Benji Heran, et al.
Pubblicazione: (2024-12-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
di: Siddiqui, S, et al.
Pubblicazione: (2018)

The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
di: Russell, R, et al.
Pubblicazione: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
di: Siddiqui SH, et al.
Pubblicazione: (2018-11-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
di: Holly R. Keir, et al.
Pubblicazione: (2021-09-01)

How inhaled corticosteroids target inflammation in COPD
di: Simon Lea, et al.
Pubblicazione: (2023-10-01)

Rational use of inhaled corticosteroids for the treatment of COPD
di: Jennifer K. Quint, et al.
Pubblicazione: (2023-07-01)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
di: Berry, M, et al.
Pubblicazione: (2007)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
di: Green, R, et al.
Pubblicazione: (2006)

Reply to: inhaled corticosteroids and adult asthma
di: Beasley, R, et al.
Pubblicazione: (2019)

Counterpoint: Should an attempt be made to withdraw inhaled corticosteroids in all patients with stable GOLD 3 (30% ≤ FEV1 < 50% predicted) COPD? No.
di: Pavord, I
Pubblicazione: (2018)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
di: Green, R, et al.
Pubblicazione: (2002)

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
di: Ricardo G. Figueiredo, et al.
Pubblicazione: (2022-08-01)

The dose of inhaled corticosteroids in patients with COPD: when less is better
di: Izquierdo JL, et al.
Pubblicazione: (2018-10-01)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
di: Koehorst-ter Huurne K, et al.
Pubblicazione: (2016-07-01)

COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
di: Ozcakir S, et al.
Pubblicazione: (2020-10-01)

Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
di: Liu SF, et al.
Pubblicazione: (2016-07-01)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
di: Cheng S, et al.
Pubblicazione: (2017-07-01)

Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short
di: Tantucci C, et al.
Pubblicazione: (2020-04-01)

Prevalence and clinical features of asthma-COPD overlap in patients with COPD not using inhaled corticosteroids
di: Kuniaki Hirai, et al.
Pubblicazione: (2021-01-01)

Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
di: Soltani A, et al.
Pubblicazione: (2016-09-01)

Biomarkers predicting response to corticosteroid therapy in asthma.
di: Brightling, C, et al.
Pubblicazione: (2005)

Asthma progression and mortality: The role of inhaled corticosteroids
di: O'Byrne, P, et al.
Pubblicazione: (2019)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
di: Antonio Oliver, et al.
Pubblicazione: (2021-01-01)

Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment
di: Lucie Blais, et al.
Pubblicazione: (2004-01-01)

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
di: Miravitlles M, et al.
Pubblicazione: (2022-01-01)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
di: Cataldo D, et al.
Pubblicazione: (2018-07-01)

Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
di: Koehorst-ter Huurne K, et al.
Pubblicazione: (2018-09-01)

Non-eosinophilic corticosteroid unresponsive asthma.
di: Pavord, I, et al.
Pubblicazione: (1999)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
di: Janson C, et al.
Pubblicazione: (2017-10-01)

Prednisolone response in patients with COPD.
di: Pavord, I, et al.
Pubblicazione: (2004)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
di: Bafadhel, M, et al.
Pubblicazione: (2009)

Inhaled Corticosteroids
di: Peter J. Barnes
Pubblicazione: (2010-03-01)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
di: Bloom CI, et al.
Pubblicazione: (2020-04-01)

Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary
di: Amnon Ariel, et al.
Pubblicazione: (2023-11-01)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
di: Mario Cazzola, et al.
Pubblicazione: (2023-07-01)

A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
di: Smit Patel, et al.
Pubblicazione: (2022-07-01)